ArticleTranslational cancer research2026
Cuprotosis-related gene subtypes, prognostic modeling, and tumor microenvironment remodeling in breast cancer.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A newly discovered mode of cell death is called cuprotosis. Current evidence confirms that cuprotosis is involved in the occurrence and development of malignant tumors. However, the prognostic significance and function of cuprotosis-related genes (CRGs) in breast cancer (BC) remain unclear. The aim of this study is to establish a model for predicting the prognosis of BC patients with cuprotosis-related pattern-related gene (CRPRG) score, and explore the functional role of CRGs in the tumor microenvironment (TME). Methods: In this study, transcriptome profiles, corresponding clinical information and tumor mutation data were collected from The Cancer Genome Atlas (TCGA) database and the Gene Expression Omnibus (GEO) database (GSE20685). The multigene prediction model was constructed using the least absolute shrinkage and selection operator (LASSO) and Cox regression analysis, and then validated by Kaplan-Meier and receiver operating characteristic (ROC) analysis. Results: Using LASSO analysis and Cox regression analysis, we screened out eight cuprotosis-related pattern genes (including Conclusions: In conclusion, we identified two CRG subtypes and three cuprotosis-related differentially expressed gene (DEG) clusters in BC. CRPRG score has shown good performance in predicting the prognosis and efficacy of treatments for BC and is expected to provide potential biological therapeutic targets for BC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.